Page 8 - Project Orbis News Today

KIMMTRAK has been approved in Canada and Australia for the treatment of an aggressive form of ocular melanoma and follows approval in the United States and the European Union PETACH TIKVAH, Israel, June 8, 2022 /PRNewswire/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, is pleased to announce the approval of KIMMTRAK(tebentafusp) by Health Canada and Therapeutics Goods Admini...

KIMMTRAK has been approved in Canada and Australia for the treatment of an aggressive form of ocular melanoma and follows approval in the United States and the European Union PETACH TIKVAH

/PRNewswire/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in...

KIMMTRAK has been approved in Canada and Australia for the treatment of an aggressive form of ocular melanoma and follows approval in the United

KIMMTRAK has been approved in Canada and Australia for the treatment of an aggressive form of ocular melanoma and follows approval in the United States and the European Union PETACH TIKVAH, Israel, June 8, 2022 /PRNewswire/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets,...

The U.S. Food and Drug Administration ((FDA)) approved AstraZeneca (AZN) and Daiichi Sankyo's (DSKYF) (DSNKY) Enhertu to treat certain patients with breast cancer.Enhertu...

/PRNewswire/ -- The Bloomberg New Economy International Cancer Coalition (the "Coalition") today called for a permanent paradigm change in the way cancer...

A new consensus paper was published in Nature Medicine by 35 members of Bloomberg New Economy International Cancer Coalition.

The UK’s NICE has recommended Merck’s tepmetko (tepotinib) to treat adult patients with advanced non-small cell lung cancer (NSCLC).

Takeda’s EXKIVITY▼(mobocertinib) granted Conditional Marketing Authorisation in Great Britain ·         Takeda UK Ltd. is pleased to announce that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorisation...